Gyre Therapeutics FY revenue rises 10.2% to $116.6M
Gyre Therapeutics (NASDAQ:GYRE) reported a year of strategic transformation and steady financial growth for the full year 2025, posting total revenue of $116.6 million, a 10.2% increase compared to the prior year.























